NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
25.59
+0.67 (2.69%)
Sep 2, 2026, 4:00 PM EDT - Market closed
NewAmsterdam Pharma Company Employees
NewAmsterdam Pharma Company had 100 employees as of December 31, 2025. The number of employees increased by 32 or 47.06% compared to the previous year.
Employees
100
Change
32
Growth
47.06%
Revenue / Employee
$71,210
Profits / Employee
-$2,595,040
Market Cap
3.06B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 100 | 32 | 47.06% |
| Mar 31, 2025 | 77 | 37 | 92.50% |
| Dec 31, 2024 | 68 | 39 | 134.48% |
| Sep 30, 2024 | 62 | 40 | 181.82% |
| Jun 30, 2024 | 57 | 35 | 159.09% |
| Mar 31, 2024 | 40 | 23 | 135.29% |
| Dec 31, 2023 | 29 | 12 | 70.59% |
| Jun 30, 2023 | 22 | - | - |
| Dec 31, 2022 | 17 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,784 |
| Beam Therapeutics | 540 |
| Tarsus Pharmaceuticals | 370 |
| Arcutis Biotherapeutics | 354 |
| Structure Therapeutics | 281 |
| Immunome | 247 |
| Alumis | 239 |
| Celldex Therapeutics | 198 |
NAMS News
- 21 hours ago - NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in September - GlobeNewsWire
- 7 days ago - NewAmsterdam Pharma Announces Upcoming Presentations at the European Society of Cardiology (ESC) Congress 2026 - GlobeNewsWire
- 27 days ago - NewAmsterdam Pharma price target lowered to $50 from $51 at RBC Capital - TheFly
- 4 weeks ago - NewAmsterdam Pharma Company Transcript: Investor Day 2026 - Transcripts
- 4 weeks ago - NewAmsterdam Pharma Company Slides: FY 2026 - Filings
- 4 weeks ago - NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial Results - GlobeNewsWire
- 4 weeks ago - NewAmsterdam Pharma Company Quarterly report: Q2 2026 - Filings
- 4 weeks ago - NewAmsterdam Pharma Company Earnings release: Q2 2026 - Filings